Pharmaceutical formulations comprising human insulin, human C-pe

Details Pharmaceutical formulations comprising human insulin, human C-pe Pharmaceutical formulations comprising human insulin, human C-pe

1984-12-17

1987-03-24

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

A61K 3726

Patent

active

046525483

ABSTRACT:
A pharmaceutical composition which comprises, in association with a pharmaceutically acceptable carrier, human insulin, human C-peptide, and human proinsulin, said human C-peptide being present in a molar ratio, human insulin to human C-peptide, of from about 1:4 to about 4:1, and said human proinsulin being present in a weight ratio, human insulin to human proinsulin, of from about 1:100 to about 100:1, is useful in treating diabetics and in promoting attainment of natural hormonal homeostasis, thereby preventing or substantially diminishing or retarding diabetic complications.

REFERENCES:
patent: 3868358 (1975-02-01), Jackson
Oyer, et al., J. Biol. Chem. 246, 1375-1386 (1971).
Yu, et al., J. Biol. Chem. 248, 3753-3761 (1973).
Horwitz, et al., J. Clin. Invest. 55, 1278-1283 (1975).
Kitabchi, Metabolism 26, 547-587 (1977).
Yanaihara, et al., Diabetes 27 (Suppl. 1), 149-160 (1978).
Yanaihara, et al., Characterization of Synthetic Human Proinsulin and C-peptide, Proinsulin, Insulin, C-peptide 41-49 (Excerpta Medica, 1979).
Rees, et al., Diabetes 18, 341 (1969).
Galloway, et al., Diabetes 18, 341 (1969).
Galloway, et al., J. Lab. Clin. Med. 78, 991-992 (1971).
Kitabchi, South. Med. J. 65, 833-838 (1972).
Low, et al., Nature 248, 339-340, (1974).
Starr, et al., J. Clin. Endocrinol. Metab. 38, 305-308 (1974).
Tompkins et al., Diabetologia 20, 94-101 (1981).
Fineberg, et al., Diabetes 22, 676-686 (1973).
Horwitz, et al., N. Engl. J. Med. 295, 207-209 (1976).
Steiner, et al., New Aspects of Insulin Biosynthesis, Proinsulin, Insulin, C-peptide 9-19 (Excerpta Medica, 1979).
Kaneko, et al., Insulin and C-peptide Secretion in Animals, Proinsulin Insulin, C-peptide 138-147 (Excerpta Medica, 1979).

Affiliated with

Also associated with

Rating

Pharmaceutical formulations comprising human insulin, human C-pe does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulations comprising human insulin, human C-pe, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations comprising human insulin, human C-pe will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1354004